Linked Life Data

16646370

Source:http://linkedlifedata.com/resource/pubmed/id/16646370

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
59
pubmed:dateCreated
2006-5-1
pubmed:abstractText
The impact of a systematic generic substitution and of the new drug pricing system (implemented in 2002 for cost saving reasons) on prescription cost was computed on the basis of prescriptions delivered in January 1999 for patients leaving our university hospital. A total of 3,099 prescriptions, representing 5,514 drugs, were delivered in one month, of which 335 (6%) were excluded (drug not available in 2002 or magistral preparations). Forced generic prescription would have saved 3,8% of global costs, while the new drug pricing system would have increased costs between 1,1% and 8,0%. In this specific setting, savings linked with forced generic drug prescription was weak (4 to 5%), and the expected savings of the new drug pricing system were not observed.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1660-9379
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
865-6, 868-71
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings].
pubmed:affiliation
Unité d'évaluation technologique, Direction médicale, Service de pharmacie, CHUV, Lausanne. jbw@chuv.ch
pubmed:publicationType
Journal Article, English Abstract